Keywords: دیپپتیدیل پپتیداز IV; Satiety; Sodium caseinate; Casein hydrolysate LFC25; GLP-1; Food intake; Simulated gastro-duodenal digestion; AA; amino acid; ANOVA; one-way analysis of variance; CCK; cholecystokinin; DPP-IV; dipeptidyl peptidase-IV; GI; gastrointestinal; GLP-1; glucagon
مقالات ISI دیپپتیدیل پپتیداز IV (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: دیپپتیدیل پپتیداز IV; ABD3; albumin-binding domain 3; ACN; acetonitrile; AUC; area under the curve; BA; bioavailability; cAMP; cyclic adenosine monophosphate; CHO; Chinese hamster ovary; DIEA; diisopropyl ethylene diamine; Cmax; peak plasma concentration; CLp; plasma clearance
Keywords: دیپپتیدیل پپتیداز IV; T1DM; type 1 diabetes; T2DM; type 2 diabetes; GIP; glucose-dependent Insulinotropic Polypeptides; DPP-IV; dipeptidyl peptidase-IV; PRDA; peptides red deer antlers; ACE; angiotensin converting enzyme; Peptides; Antidiabetic effects; Underlying mechanisms;
Keywords: دیپپتیدیل پپتیداز IV; AUC; area under the curve; BMI; body mass index; CaSR; calcium sensing receptor; CV; coefficient of variation; DPP-IV; dipeptidyl peptidase-IV; GLP-1; glucagon-like peptide-1; GPCR; G-protein coupled receptor; HV; healthy volunteer; OGTT; oral glucose tol
Keywords: دیپپتیدیل پپتیداز IV; PEP; prolyl endopeptidase; WHO; World Health Organization; CNS; central nervous system; UK; United Kingdom; MW; molecular weight; MW-SPPS; microwave-assisted solid phase peptide synthesis; RP-HPLC; reversed-phase-high-performance liquid chromatography; MA
Investigation of medicinal plants from Madagascar against DPP-IV linked to type 2 diabetes
Keywords: دیپپتیدیل پپتیداز IV; DMSO; dimethyl sulfoxide; DPP-IV; dipeptidyl peptidase-IV; GIP; glucose-dependent insulinotropic polypeptide; GLP-1; glucagon-like peptide 1; GPPN; Gly-pro-p-nitroanilide; HPLC; high-performance liquid chromatography; HR; high resolution; HRMS; high-resol
GLP-1 receptor agonist liraglutide exerts central action to induce β-cell proliferation through medulla to vagal pathway in mice
Keywords: دیپپتیدیل پپتیداز IV; Glucagon-like peptide-1; Glucose metabolism; Vagus nerve; Liraglutide; Brain stem; Pancreatic β-cell proliferation; AP; Area postrema; ARC; Arcuate nucleus; AChR; Acetylcholine receptor; α-MSH; Alpha-melanocyte-stimulating hormone; BBB; Blood brain barr
Canagliflozin potentiates GLP-1 secretion and lowers the peak of GIP secretion in rats fed a high-fat high-sucrose diet
Keywords: دیپپتیدیل پپتیداز IV; Diet-induced obesity; Canagliflozin; Glucagon-like peptide-1; Glucose-dependent insulinotropic polypeptide; Sodium-glucose cotransporter 1(SGLT1); SGLT2 inhibitor; DPP-IV; dipeptidyl peptidase-IV; GLP-1; glucagon-like peptide-1; GIP; Glucose-dependent i
Dipeptidyl peptidase-IV in chronic heart failure with reduced ejection fraction
Keywords: دیپپتیدیل پپتیداز IV; Chronic heart failure; Dipeptidyl peptidase-IV; Prognosis;
Obtaining of functional components from cooked shrimp (Penaeus vannamei) by enzymatic hydrolysis
Keywords: دیپپتیدیل پپتیداز IV; Carotenoids; Dipeptidyl peptidase-IV; Giant catfish; Prolyloligopeptidase; Shrimp
Original ArticleMelanocytes/MelanomaThe Long Noncoding RNA SPRIGHTLY Regulates Cell Proliferation in Primary Human Melanocytes
Keywords: دیپپتیدیل پپتیداز IV; CDK; cyclin-dependent kinase; DPPIV; dipeptidyl peptidase-IV; ERK; extracellular signal-regulated kinase; lncRNA; long noncoding RNA; MAPK; mitogen-activated protein kinase; MCM; minichromosome maintenance; siRNA; small interfering RNA;
Autoantibody Profile Differentiates between Inflammatory and Noninflammatory Bullous Pemphigoid
Keywords: دیپپتیدیل پپتیداز IV; autoAb; autoantibody; BP; bullous pemphigoid; BPDAI; Bullous Pemphigoid Disease Area Index; COL17; collagen XVII; DPP-4; dipeptidyl peptidase-IV; NC16A; noncollagenous 16A domain;
Alcohol-free fermented blueberry-blackberry beverage phenolic extract attenuates diet-induced obesity and blood glucose in C57BL/6J mice
Keywords: دیپپتیدیل پپتیداز IV; AFFB; alcohol-free fermented beverage; ALP; alkaline phosphatase; ALT; alanine transaminase; ANC; anthocyanin; AST; aspartate transaminase; BW; body weight; C3G; cyanidin-3-O-glucoside; DEG; differentially expressed gene; DPP-IV; dipeptidyl peptidase-IV;
The effect of dipeptidyl peptidase-IV inhibition on circulating T cell subpopulations in patients with type 2 diabetes mellitus
Keywords: دیپپتیدیل پپتیداز IV; μM; μmol/l; BMI; body mass index; CD; cluster of differentiation; DM2; diabetes mellitus type 2; DPP-IV; dipeptidyl peptidase-IV; GIP; gastric inhibitory polypeptide; GLP-1; glucagon like peptide-1; HbA1c; glycated hemoglobin; IFNgamma; interferon gamma
Recovery, viscoelastic and functional properties of Barbel skin gelatine: Investigation of anti-DPP-IV and anti-prolyl endopeptidase activities of generated gelatine polypeptides
Keywords: دیپپتیدیل پپتیداز IV; Freshwater fish; Gelatine; Hydrolysates; Dipeptidyl peptidase-IV; Prolyl endopeptidase;
Selective upregulation of the expression of plasma membrane calcium ATPase isoforms upon differentiation and 1,25(OH)2D3-vitamin treatment of colon cancer cells
Keywords: دیپپتیدیل پپتیداز IV; Calcium ATPase; PMCA isoforms; Expression; Colon cancer cells; Differentiation; 1,25(OH)2D3-vitamin; 1,25(OH)2D3; 1,25-dihydroxycholecalciferol, calcitriol; DPP-IV; dipeptidyl peptidase-IV; DMEM; Dulbecco's modified Eagle's Medium; DPBS; Dulbecco's modifi
Dipeptidyl petidase-IV inhibitor (gemigliptin) inhibits tunicamycin-induced endoplasmic reticulum stress, apoptosis and inflammation in H9c2 cardiomyocytes
Keywords: دیپپتیدیل پپتیداز IV; ROS; reactive oxygen species; GLP-1; glucagon-like peptide-1; DPP-IV; dipeptidyl peptidase-IV; Erk; extracellular signal-regulated kinases; ER; endoplasmic reticulum; IL-6; interlukin-6; TNF-α; tumor necrosis factor-α; BNP; brain natriuretic peptide; SD
Identification of novel dipeptidyl peptidase-IV and angiotensin-I-converting enzyme inhibitory peptides from meat proteins using in silico analysis
Keywords: دیپپتیدیل پپتیداز IV; MetS; metabolic syndrome; CVD; cardiovascular disease; T2D; type-2 diabetes; HBP; high blood pressure; RAAS; renin-angiotensin-aldosterone system; ACE-I; angiotensin-I-converting enzyme; DPP-IV; dipeptidyl peptidase-IV; GLP-1; glucagon-like peptide-1;
Association of GLP-1 secretion with anti-hyperlipidemic effect of ginsenosides in high-fat diet fed rats
Keywords: دیپپتیدیل پپتیداز IV; Apo B-48; apolipoprotein B-48; AUC; area under the concentration-time curve; BW; body weight; DPP-IV; dipeptidyl peptidase-IV; FBG; fasting blood glucose; FBS; fetal bovine serum; FFA; free fatty acids; GLP-1; glucagon-like peptide-1; GTS; ginseng total
Antihyperglycemic activity with DPP-IV inhibition of alkaloids from seed extract of Castanospermum australe: Investigation by experimental validation and molecular docking
Keywords: دیپپتیدیل پپتیداز IV; CAS; Castanospermum australe seed; PX-407; poloxamer-407; T2DM; Type 2 diabetes mellitus; HbA1c; glycosylated haemoglobin; OGTT; oral glucose tolerance test; KITT; insulin sensitivity index; HOMA-R; homeostasis model assessment of insulin resistance; DPP-
Vildagliptin selectively ameliorates GLP-1, GLUT4, SREBP-1c mRNA levels and stimulates β-Cell proliferation resulting in improved glucose homeostasis in rats with streptozotocin-induced diabetes
Keywords: دیپپتیدیل پپتیداز IV; Dipeptidyl peptidase-IV; Glucagon like peptide -1; Insulin; β-cell regeneration; β-cell apoptosis; Diabetes
Emerging diabetes therapies and technologies
Keywords: دیپپتیدیل پپتیداز IV; CSII; continuous subcutaneous insulin infusion; CGM; continuous glucose monitoring; DKA; diabetic ketoacidosis; DPP-IV; dipeptidyl peptidase-IV; EMEA; European Medicines Agency; FDA; Food and Drug Administration; FCL; fully closed-loop; GRAS; generally re
A novel long acting DPP-IV inhibitor PKF-275-055 stimulates β-cell proliferation resulting in improved glucose homeostasis in diabetic rats
Keywords: دیپپتیدیل پپتیداز IV; Dipeptidyl peptidase-IV; Glucagon like peptide -1; Insulin; β-cell regeneration; Diabetes
Discovery of DA-1229: A potent, long acting dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes
Keywords: دیپپتیدیل پپتیداز IV; Dipeptidyl peptidase-IV; DPP-IV; DPP-4; GLP-1; DPP-4 inhibitor; DA-1229
DPP-4 inhibitor des-F-sitagliptin treatment increased insulin exocytosis from db/db mice β cells
Keywords: دیپپتیدیل پپتیداز IV; DPP-4; dipeptidyl peptidase-IV; CCD; charge-coupled device; ELISA; enzyme-linked immunosorbent assay; GFP; green fluorescent protein; KRB; Krebs ringer buffer; TIRF; total internal reflection fluorescence; TIRFM; TIRF microscopy; t-SNARE; target membrane
Role of a propeller loop in the quaternary structure and enzymatic activity of prolyl dipeptidases DPP-IV and DPP9
Keywords: دیپپتیدیل پپتیداز IV; DPP-IV; dipeptidyl peptidase IV; DPP; dipeptidyl peptidase; POP; prolyl oligopeptidase; H-Gly-Pro-pNA; HGly-Pro-p-nitroanilide; DTT; dithiothreitol; AUC; analytical ultracentrifugation; CD; circular dichroism; FAP; fibroblast activation protein; ADA; aden
RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes
Keywords: دیپپتیدیل پپتیداز IV; Dipeptidyl peptidase-IV; Glucagon-like peptide-1; Type 2 diabetes mellitus; Anti-diabetic effect; Oral glucose tolerance test
Combination of TS-021 with metformin improves hyperglycemia and synergistically increases pancreatic β-cell mass in a mouse model of type 2 diabetes
Keywords: دیپپتیدیل پپتیداز IV; Dipeptidyl peptidase-IV; Insulin; Incretin; Pancreatic islet; High fat diet; Streptozotocin; Oral glucose tolerance test;
Discovery of carmegliptin: A potent and long-acting dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
Keywords: دیپپتیدیل پپتیداز IV; Dipeptidyl peptidase-IV; Glucagon-like peptide 1; Structure-based drug design
Inhibition of multifunctional dipeptidyl peptidase-IV: Is there a risk of oncological and immunological adverse effects?
Keywords: دیپپتیدیل پپتیداز IV; Diabetes mellitus; Dipeptidyl peptidase-IV; DPP-IV inhibitors; Drug safety; Immune suppression; Cancer
Piperidinyl-2-phenethylamino inhibitors of DPP-IV for the treatment of Type 2 diabetes
Keywords: دیپپتیدیل پپتیداز IV; Dipeptidyl peptidase-IV; DPP-IV; Phenethylamine
Aminopiperidine-fused imidazoles as dipeptidyl peptidase-IV inhibitors
Keywords: دیپپتیدیل پپتیداز IV; Dipeptidyl peptidase-IV; DPP-4; DPP-IV; Dipeptidyl peptidase 8; DPP-8; DPP-9; Quiescient peptidyl peptidase; QPP; GLP-1; Glucagon-like peptide 1; Benzimidazole; Imidazopyridine; Buchwald coupling; Sitagliptin;
Effects of the combination of dipeptidyl peptidase-IV inhibitor ASP8497 and antidiabetic drugs in streptozotocin-nicotinamide-induced mildly diabetic mice
Keywords: دیپپتیدیل پپتیداز IV; Dipeptidyl peptidase-IV; Glucagon-like peptide-1; Insulin; Blood glucose; Diabetes; ASP8497
Effects of the dipeptidyl peptidase-IV inhibitor ASP8497 on glucose tolerance in animal models of secondary failure
Keywords: دیپپتیدیل پپتیداز IV; ASP8497; Dipeptidyl peptidase-IV; Glucagon-like peptide-1; Diabetes; Sulfonylurea; Secondary failure
Growth factor based therapies and intestinal disease: Is glucagon-like peptide-2 the new way forward?
Keywords: دیپپتیدیل پپتیداز IV; Dipeptidyl peptidase-IV; Glucagon-like peptide-2; Inflammatory bowel disease; Animal model
Antihyperglycemic effects of ASP8497 in streptozotocin-nicotinamide induced diabetic rats: comparison with other dipeptidyl peptidase-IV inhibitors
Keywords: دیپپتیدیل پپتیداز IV; dipeptidyl peptidase-IV; glucagon-like peptide-1; insulin; diabetes; ASP8497
Decreased dipeptidyl peptidase-IV activity and glucagon-like peptide-1(7-36)amide degradation in type 2 diabetic subjects
Keywords: دیپپتیدیل پپتیداز IV; Dipeptidyl peptidase-IV; Glucagon-like peptide-1; Type 2 diabetes;
ASP8497 is a novel selective and competitive dipeptidyl peptidase-IV inhibitor with antihyperglycemic activity
Keywords: دیپپتیدیل پپتیداز IV; Dipeptidyl peptidase-IV; Glucagon-like peptide-1; Insulin; Diabetes
Evaluation of therapeutic potentials of site-specific PEGylated glucagon-like peptide-1 isomers as a type 2 anti-diabetic treatment: Insulinotropic activity, glucose-stabilizing capability, and proteolytic stability
Keywords: دیپپتیدیل پپتیداز IV; Glucagons-like peptide-1; Type-2 diabetes; Dipeptidyl peptidase-IV; Neutral endopeptidase 24.11; PEGylation
The reversed binding of β-phenethylamine inhibitors of DPP-IV: X-ray structures and properties of novel fragment and elaborated inhibitors
Keywords: دیپپتیدیل پپتیداز IV; Dipeptidyl peptidase-IV; DPP-IV; Type 2 diabetes; Glucagon-like peptide-1; GLP-1
E3024, 3-but-2-ynyl-5-methyl-2-piperazin-1-yl-3,5-dihydro-4H-imidazo[4,5-d]pyridazin-4-one tosylate, is a novel, selective and competitive dipeptidyl peptidase-IV inhibitor
Keywords: دیپپتیدیل پپتیداز IV; Dipeptidyl peptidase-IV; Dipeptidyl peptidase 8; Dipeptidyl peptidase 9; Glucagon-like Peptide-1; Insulin
DPPIV inhibitors extend GLP-2 mediated tumour promoting effects on intestinal cancer cells
Keywords: دیپپتیدیل پپتیداز IV; Glucagon-like peptide; Dipeptidyl peptidase-IV; Proliferation; Migration
KR-62436, 6-{2-[2-(5-cyano-4,5-dihydropyrazol-1-yl)-2-oxoethylamino]ethylamino}nicotinonitrile, is a novel dipeptidyl peptidase-IV (DPP-IV) inhibitor with anti-hyperglycemic activity
Keywords: دیپپتیدیل پپتیداز IV; Dipeptidyl peptidase-IV; Glucagon-like peptide-1; Insulin; Oral glucose tolerance test; Ob/ob mice;